STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$17.36
-0.48 (-2.69%)
▼
5d:
+2.48%
30d:
-6.97%
90d:
+29.26%
BUY
HIGH Confidence
Analysis Updated: Jun 29, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: STVN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.52
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$19.57
11.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $17.36, which is considered slightly low relative to its 30-day fair value range of $17.08 to $18.49. The stock's valuation (Forward PE: 20.7) is in line with its historical norms (22.0). Remarkably, the market is currently pricing in an annual earnings decline of 2.0% over the next few years. This pessimistic expectation contrasts with the company's recent 2.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $16.27, while resistance sits at $18.67.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.45 (+40.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STVN is in a strong uptrend. Immediate support is located at $16.27, while resistance sits at $18.67.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.45 (+40.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$17.08 -
$18.49
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.8% below Wall St target ($24.45)
Trading Range Analysis
30-Day Trading Range
$17.08 -
$18.49
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$16.27
Resistance Level
$18.67
Current Trend
Strong Uptrend
Technical data as of
Jun 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.72
Wall Street Target
$24.45
(+40.8%)
Revenue Growth (YoY)
6.6%
Earnings Growth (YoY)
2.9%
Profit Margin
11.8%
Valuation Discount vs History
-2.0% cheaper
PE vs Historical
20.7 vs 22.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.0%
(market-implied from PE analysis)
1-Year Target
$17.01
(-2%)
2-Year Target
$16.67
(-4%)
3-Year Target
$16.34
(-6%)
3-Yr Target (if PE normalizes)
(PE: 21→22)
$17.35
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 18.9%)
$30.70
(+77%)
Base:
(SPY PE: 20.7, Growth: 18.9%)
$29.20
(+68%)
Bear:
(PE: 17.6, Growth: 18.9%)
$24.82
(+43%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 30.76 | Current EPS (TTM): $0.58
Bull Case
$28.35
(+63%)
Analyst growth 44.5%, PE expands to 33.8
Base Case
$25.78
(+49%)
Market implied 44.5%, PE stable at 30.8
Bear Case
$12.13
(-30%)
Severe decline -20.0%, PE contracts to 26.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.7 to 22.0
Stabilization Target:
$18.44
(+6.2%)
PE Expansion Potential:
+6.2%
Share & Embed Analysis
Last updated: June 30, 2026 7:07 AM ET
Data refreshes hourly during market hours. Next update: 8:07 AM
Data refreshes hourly during market hours. Next update: 8:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
